Cart
sales@molnova.com
hCYP3A4 Fluorogenic substrate 1
CAS No. 186299-00-3
hCYP3A4 Fluorogenic substrate 1( —— )
Catalog No. M37062 CAS No. 186299-00-3
hCYP3A4 Fluorogenic substrate 1, a phthalimide derivative, exhibits low activity against COX.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 79 | Get Quote |
|
| 5MG | 117 | Get Quote |
|
| 10MG | 187 | Get Quote |
|
| 25MG | 364 | Get Quote |
|
| 50MG | 579 | Get Quote |
|
| 100MG | 888 | Get Quote |
|
| 500MG | 1782 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamehCYP3A4 Fluorogenic substrate 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionhCYP3A4 Fluorogenic substrate 1, a phthalimide derivative, exhibits low activity against COX.
-
DescriptionhCYP3A4 Fluorogenic substrate 1 is a potrnt hCYP3A4 fluorogenic substrate with an Km value of 0.36 μM. hCYP3A4 Fluorogenic substrate 1 can be used for cell and in vivo imaging.
-
In Vitro——
-
In VivoAnimal Model:Male Sprague-Dawley ratsDosage:10 mg/kg Administration:I.v.Result:Can be used as a probe substrate offers a highly efficient and easy-to-use approach for screening and characterizing hCYP3A4 inhibitors or time-dependent inactivators, which strongly facilitates hCYP3A4-mediated DDI studies.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number186299-00-3
-
Formula Weight305.3
-
Molecular FormulaC19H12FNO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (40.94 mM; Ultrasonic (<60°C)
-
SMILESO=C1C=2C=3C(C(=O)N1CC4=CC=C(F)C=C4)=CC=CC3C=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. He RJ, et al. Rationally Engineered CYP3A4 Fluorogenic Substrates for Functional Imaging Analysis and Drug-Drug Interaction Studies. J Med Chem. 2023 May 25;66(10):6743-6755.?
molnova catalog
related products
-
Vitacoxib
A potent, selective COX-2 inhibitor with IC50 of 0.34 ug/mL.
-
CAY10404
CAY10404 is a potent and highly selective inhibitor of COX-2 and COX-1. It is also a potent inhibitor of PKB/Akt and MAPK signalling pathways and induces apoptosis in NSCLC cells, with analgesic, anti-inflammatory and anti-cancer activities.
-
TFAP
TFAP is a selective cyclooxygenase-1 (COX-1) inhibitor.
